Drug therapy for solitary cysticercus granuloma: A systematic review and meta-analysis

Neurology

Volumn 80, Issue 2, 2013, Pages 152-162

  Otte, Willem M ^a,b   Singla, Monika ^c   Sander, Josemir W ^d,e   Singh, Gagandeep ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CONTRAST MEDIUM; METHYLPREDNISOLONE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PLACEBO; PRAZIQUANTEL; PREDNISOLONE;

ANTICONVULSANT THERAPY; ANTIMICROBIAL THERAPY; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; GRANULOMA; HUMAN; IMAGE ANALYSIS; META ANALYSIS; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SOLITARY CYSTICERCUS GRANULOMA; SYSTEMATIC REVIEW; TAENIA;

ADOLESCENT; ALBENDAZOLE; ANTHELMINTICS; ANTI-INFLAMMATORY AGENTS; CALCINOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOMA; HUMANS; INFANT; MALE; NEUROCYSTICERCOSIS; ODDS RATIO; PRAZIQUANTEL; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873671141     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827b90a8     Document Type: Review

References (40)

1. Garcia HH, Gonzalez AE, Evans CA, Gilman RH. Taenia solium cysticercosis. Lancet 2003;362:547-556. (Pubitemid 36976722)
2. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000;68:137-143. (Pubitemid 30245834)
3. Croker C, Redelings M, Reporter R, Sorvillo F, Mascola L, Wilkins P. The impact of neurocysticercosis in California: a review of hospitalized cases. PLoS Negl Trop Dis 2012; 6:e1486.
4. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002;8:608-613. (Pubitemid 34556362)
5. DeGiorgio CM, Sorvillo F, Escueta SP. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2005;64:1486.
6. Earnest MP, Reller LB, Filley CM, Grek AJ. Neurocysti-cercosis in the United States: 35 cases and a review. Rev Infect Dis 1987;9:961-979.
7. Guerra LG, Cuetter AC. Neurocysticercosis in the southwestern United States. Am Fam Physician 1993;48:1223.
8. Singh G, Rajshekhar V, Murthy JM, et al. A diagnostic and therapeutic scheme for a solitary cysticercus granu-loma. Neurology 2010;75:2236-2245.
9. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559-1564. (Pubitemid 39507569)
10. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010;1:CD000215.
11. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albenda-zole and praziquantel. Ann Intern Med 2006;145:43-51. (Pubitemid 46780606)
12. Mazumdar M, Pandharipande P, Poduri A. Does albenda-zole affect seizure remission and computed tomography response in children with neurocysticercosis? A Systematic review and meta-analysis. J Child Neurol 2007;22:135-142. (Pubitemid 46860410)
13. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of anti-parasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258. (Pubitemid 38067637)
14. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465-470.
15. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-46. (Pubitemid 32682008)
16. de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K. Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution. J Neurol Sci 2010;288:135-141.
17. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Mor-phometry of single small enhancing computed tomo-graphic lesions: outcome and effect of albendazole therapy. J Trop Pediatr 2002;48:219-224.
18. de Souza A, Thennarasu K, Yeshraj G, Kovoor JME, Nalini A. Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome. J Neurol Sci 2009;276:108-114.
19. Gupta M, Agarwal P, Khwaja GA, et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurol India 2002;50:145-147. (Pubitemid 34873809)
20. Kaushal S, Rani A, Chopra S, Singh G. Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. Neurol India 2006;54:157-160. (Pubitemid 44015016)
21. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004;62:2236-2240. (Pubitemid 38787781)
22. Verma A, Misra S. Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol Scand 2006;113:174-177.
23. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008;79:1050-1055.
24. Das K, Mondal GP, Banerjee M, Mukherjee BB, Singh OP. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study. J Clin Neurosci 2007;14:1172-1177. (Pubitemid 350102785)
25. Garcia HH, Gilman RH, Horton J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Neurology 1997;48:1421-1427. (Pubitemid 27240575)
26. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in neurocysticercosis. Natl Med J India 1995;8:255-258.
27. Goel D, Mittal M, Bansal KK, Singhal A. Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India. Acta Neurol Scand 2010;121:204-208.
28. Kaur P, Dhiman P, Dhawan N, Nijhawan R, Pandit S. Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion. Neurol India 2010;58:560-564.
29. Medina MT, Genton P, Montoya MC, Cordova S, Dravet C, Sotelo J. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial. Epilepsia 1993;34:1024-1027. (Pubitemid 24004238)
30. Thussu A, Arora A, Lal V, Prabhakar S, Sawhney IM. Albendazole therapy for solitary persistent cysticercus gran-uloma. Neurol India 2001;49:95-97. (Pubitemid 32385286)
31. Alarcón F, Dueñas G, Diaz M, Cevallos N, Estrada G. Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days, and a control group without albendazole. Rev Ecuat Neurol 2001;10:1-2.
32. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998;17:696-700. (Pubitemid 28388158)
33. Chaurasia RN, Garg RK, Agarwall A, et al. Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study. Southeast Asian J Trop Med Public Health 2010; 41:517-525.
34. de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K. Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: a prospective study using serial magnetization transfer imaging. Epilepsia 2011;52:1918-1927.
35. Gogia S, Talukdar B, Choudhury V, Arora BS. Neuro-cysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003;97:416-421. (Pubitemid 39186023)
36. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003;143:111-114. (Pubitemid 36928577)
37. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44: 1344-1346. (Pubitemid 24232245)
38. Pretell EJ, Garcia HH, Custodio N, et al. Short regimen of praziquantel in the treatment of single brain enhancing lesions. Clin Neurol Neurosurg 2000;102:215-218. (Pubitemid 32012617)
39. Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticer-cosis. J Child Neurol 2004;19:323-327. (Pubitemid 38867941)
40. Thussu A, Chattopadhyay A, Sawhney IMS, Khandelwal N. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J Neurol Neurosurg Psychiatry 2008;79:272-275. (Pubitemid 351303381)